Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Changes in HLA-DR expression, cytokine production and coagulation following endotoxin infusion in healthy human volunteers.

Mant TG, Borozdenkova S, Bradford DB, Allen E, Amin DM, Toothaker RD, Collins RW, Hargreaves RE, Jurcevic S.

Int Immunopharmacol. 2008 May;8(5):701-7. doi: 10.1016/j.intimp.2008.01.014. Epub 2008 Feb 11.

PMID:
18387512
2.

Influence of coadministration on the pharmacokinetics of azimilide dihydrochloride and digoxin.

Toothaker RD, Corey AE, Valentine SN, Agnew JR, Parekh N, Moehrke W, Thompson GA, Powell JH.

J Clin Pharmacol. 2005 Jul;45(7):773-80.

PMID:
15951467
4.

Absence of pharmacokinetic interaction between orally co-administered naproxen sodium and diphenhydramine hydrochloride.

Toothaker RD, Barker SH, Gillen MV, Helsinger SA, Kindberg CG, Hunt TL, Powell JH.

Biopharm Drug Dispos. 2000 Sep;21(6):229-33.

PMID:
11304721
5.

Effects of oral cimetidine or ranitidine on the pharmacokinetics of intravenous enoxacin.

Misiak PM, Eldon MA, Toothaker RD, Sedman AJ.

J Clin Pharmacol. 1993 Jan;33(1):53-6.

PMID:
8429114
6.

Effect of gastric acidity on enoxacin absorption.

Lebsack ME, Nix D, Ryerson B, Toothaker RD, Welage L, Norman AM, Schentag JJ, Sedman AJ.

Clin Pharmacol Ther. 1992 Sep;52(3):252-6.

PMID:
1526081
7.

Theophylline dosage adjustment during enoxacin coadministration.

Koup JR, Toothaker RD, Posvar E, Sedman AJ, Colburn WA.

Antimicrob Agents Chemother. 1990 May;34(5):803-7.

8.

In vitro evaluation of the determinants of bactericidal activity of ampicillin dosing regimens against Escherichia coli.

White CA, Toothaker RD, Smith AL, Slattery JT.

Antimicrob Agents Chemother. 1989 Jul;33(7):1046-51.

9.

Enoxacin absorption and elimination characteristics.

Toothaker RD.

Clin Pharmacokinet. 1989;16 Suppl 1:52-8. Review.

PMID:
2653697
10.

The theophylline-enoxacin interaction: I. Effect of enoxacin dose size on theophylline disposition.

Rogge MC, Solomon WR, Sedman AJ, Welling PG, Toothaker RD, Wagner JG.

Clin Pharmacol Ther. 1988 Nov;44(5):579-87.

11.

Correction for bacterial loss in in vitro dilution models.

White CA, Toothaker RD, Smith AL, Slattery JT.

Antimicrob Agents Chemother. 1987 Nov;31(11):1859-60.

12.

Determination of quinapril and its active metabolite in human plasma and urine by gas chromatography with electron-capture detection.

Ferry JJ, Horvath AM, Easton-Taylor M, Toothaker RD, Colburn WA.

J Chromatogr. 1987 Oct 9;421(1):187-91. No abstract available.

PMID:
3429565
13.

Recent analytical methods for cephalosporins in biological fluids.

Toothaker RD, Wright DS, Pachla LA.

Antimicrob Agents Chemother. 1987 Aug;31(8):1157-63.

14.

Controversy. II: Bioequivalence as an indicator of therapeutic equivalence: modeling the theoretic influence of bioinequivalence on single-dose drug effect.

Olson SC, Eldon MA, Toothaker RD, Ferry JJ, Colburn WA.

J Clin Pharmacol. 1987 May-Jun;27(5):342-5. No abstract available.

PMID:
3693579
15.

The influence of food on the oral absorption of bevantolol.

Toothaker RD, Randinitis EJ, Nelson C, Kinkel AW, Goulet JR.

J Clin Pharmacol. 1987 Apr;27(4):297-9.

PMID:
2890668
16.

Influence of ampicillin elimination half-life on in-vitro bactericidal effect.

White CA, Toothaker RD.

J Antimicrob Chemother. 1985 Jan;15 Suppl A:257-60.

PMID:
3980329
17.

Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii.

Toothaker RD, Elmer GW.

Antimicrob Agents Chemother. 1984 Oct;26(4):552-6.

18.

Experimental meningitis in the rat: Haemophilus influenzae.

Smith AL, Greenfield MD, Toothaker RD.

Infection. 1984;12 Suppl 1:S11-22. Review.

PMID:
6397447
19.

Effect of dose size on the pharmacokinetics of oral hydrocortisone suspension.

Toothaker RD, Craig WA, Welling PG.

J Pharm Sci. 1982 Oct;71(10):1182-5.

PMID:
7143223
20.

An in vitro model for the study of antibacterial dosage regimen design.

Toothaker RD, Welling PG, Craig WA.

J Pharm Sci. 1982 Aug;71(8):861-4.

PMID:
7120086
21.

Oral hydrocortisone pharmacokinetics: a comparison of fluorescence and ultraviolet high-pressure liquid chromatographic assays for hydrocortisone in plasma.

Toothaker RD, Sundaresan GM, Hunt JP, Goehl TJ, Rotenberg KS, Prasad VK, Craig WA, Welling PG.

J Pharm Sci. 1982 May;71(5):573-6.

PMID:
7097506
22.
23.

Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assays.

Bundtzen RW, Toothaker RD, Nielson OS, Madsen PO, Welling PG, Craig WA.

Antimicrob Agents Chemother. 1981 Mar;19(3):443-9.

24.

Suppression of endogenous hydrocortisone with dexamethasone.

Goehl TJ, Sundaresan GM, Hunt JP, Prasad VK, Toothaker RD, Welling PG.

J Pharm Sci. 1980 Dec;69(12):1409-10.

PMID:
7463326
25.

Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.

Frimodt-Möller N, Maigaard S, Toothaker RD, Bundtzen RW, Brodey MV, Craig WA, Welling PG, Madsen PO.

Antimicrob Agents Chemother. 1980 Apr;17(4):599-607.

26.

The effect of food on drug bioavailability.

Toothaker RD, Welling PG.

Annu Rev Pharmacol Toxicol. 1980;20:173-99. Review.

PMID:
6992698
27.

Cefotaxime pharmacokinetics following a single intravenous dose to patients with varying renal function.

Nielsen OS, Toothaker RD, Bundtzen RW, Craig WA, Welling PG, Madsen PO.

Infection. 1980;8 Suppl 3:S 305-9.

PMID:
6250981

Supplemental Content

Loading ...
Support Center